Contact sites statistics
| Cell type | Contact sites | % LD with contact sites | Full coverage (% LD with contact site) | Partial coverage | Standard deviation |
|---|---|---|---|---|---|
| HeLa | ER-LD | 93% | 43.95% | 56.05% | 3.82 |
| U2OS | ER-LD | 96% | 54.25% | 45.75% | 5.38 |
| HeLa | Mito-LD | 86% | 17.33% | 82.67% | 2.98 |
| U2OS | Mito-LD | 94% | 23.67% | 76.33% | 4.84 |
| U2OS | PX-LD | 66% | 7.24% | 92.76% | 5.50 |
| Cell type | Contact sites | % LD with contact sites | Full coverage (% LD with contact site) | Partial coverage | Standard deviation |
|---|---|---|---|---|---|
| HeLa | ER-LD | 93% | 43.95% | 56.05% | 3.82 |
| U2OS | ER-LD | 96% | 54.25% | 45.75% | 5.38 |
| HeLa | Mito-LD | 86% | 17.33% | 82.67% | 2.98 |
| U2OS | Mito-LD | 94% | 23.67% | 76.33% | 4.84 |
| U2OS | PX-LD | 66% | 7.24% | 92.76% | 5.50 |
ER, endoplasmic reticulum; LD, lipid droplet; mito, mitochondria; PX, peroxisome.
Sharing content requires targeting cookies to be enabled. Please update your cookie preferences to use this feature.